Skip to content

Gold recovers as Moderna’s Delta variant-effective vaccine quells concerns

Gold recovers as Moderna's Delta variant-effective vaccine quells concerns
Jordan Major

Gold prices rebounded yesterday after falling to their lowest level since mid-April on Tuesday. The bounceback seems to be sparked by reports that Moderna’s Covid-19 vaccine was effective against the virus’s robust Delta version, which is currently causing fresh lockdowns in several nations.

Moderna vaccine’s success appeared to alleviate fears about long-term economic disruption, fueling speculation that earlier-than-expected monetary tightening may reduce the attraction of non-yielding bullion. 

Presently Gold prices remain above support in the $1,755 – $1,765 zone, although bullish RSI divergence indicates that downward impetus has waned. While this might be nothing more than a digestion phase, it could also be the start of an upturn.

Price of Gold US$/OZ. Source: TradingView.com

The $1,797 – $1,808 zone represents near-term resistance, with a break above that confirmed on a daily closing basis opening the door to a climb toward $1850. On the other hand, a breakdown of support may pave the way for a test of the March low at $1676.10.

Where is next for gold

As previously reported by Finbold, the World Bank projects, the price of gold will continue to fall in 2021 and 2022 as demand in major countries remains constrained. 

By the same token, Trading Economics experts predict that gold will enter a downtrend during the following 12 months, based on the Federal Reserve’s operations.

Moreover, the statistics released in the PCE report on Friday reinforced the possibility of future inflation, but the lack of an upside surprise helped gold regain some support; it appears that gold is anticipated to trade between $1,750/t oz. and $1,400/t oz. over the next 12 months.

Prices reach an all-time high

The June ISM manufacturing survey is likely to reveal that the rate of sector activity growth has decreased for the third month in a row. Analogous Markit PMI data connects the slowdown to capacity limitations, such as inequitable supply chains and labor shortages.

Moreover, June’s official US jobs data is due out on Friday, with traders keeping a watchful eye for signs of payroll growth and wage inflation, both of which are viewed as critical inputs into the Fed’s calculations.

Inflation has continued to rise with increasing raw material costs causing a record-breaking surge in input inflation. Furthermore, companies have not shied away from passing on greater expenses to customers, with final prices also reaching an all-time high.

Despite the month-on-month slowdown, ISM data reflects this may boost betting on a faster hawkish turn at the Federal Reserve, which would likely raise front-end rates and the US dollar, further hurting gold prices.

[robinhood]

Best Crypto Exchange for Intermediate Traders and Investors

  • Invest in cryptocurrencies and 3,000+ other assets including stocks and precious metals.

  • 0% commission on stocks - buy in bulk or just a fraction from as little as $10. Other fees apply. For more information, visit etoro.com/trading/fees.

  • Copy top-performing traders in real time, automatically.

  • eToro USA is registered with FINRA for securities trading.

30+ million Users
Securities trading offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. Finbold.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD

Read Next:

Finance Digest

By subscribing you agree with Finbold T&C’s & Privacy Policy

Related posts

Sign Up

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

Already have an account? Sign In

Services

Disclaimer: The information on this website is for general informational and educational purposes only and does not constitute financial, legal, tax, or investment advice. This site does not make any financial promotions, and all content is strictly informational. By using this site, you agree to our full disclaimer and terms of use. For more information, please read our complete Global Disclaimer.